This message was sent to ##Email##
|
| May 13, 2020 |
| |  | | |
|
| |
Cancer Network
A study published in JAMA Network Open, found that raising the awareness of general practitioners (GPs) and drawing attention to the importance of encouraging immigrant women to participate in cervical cancer screening (CCS) is a feasible and effective strategy to increase participation in the program.
READ MORE
ASCT
Voting is now open for ASCT’s next president-elect and regional directors for regions 1,3, and 5. The candidates are:
Nominee for president-elect:
Donna K. Russell,
M.Ed., CT(ASCP)HT, CMIAC
Rochester Medical Center
Rochester, NY
Nominee for region 1 director (Alaska, California, Hawaii, Idaho, Montana, Oregon, Washington, Western Canada):
James Matthew (Matt) Riding, SCT(ASCP)CM
Program Director/Clinical Instructor School of Cytotechnology Allied Health Professions
Loma Linda University
Loma Linda, CA
Nominee for region 3 director (Arkansas, Illinois, Indiana, Louisiana, Michigan, Mississippi, Ohio, Oklahoma, Texas):
Stacy L. Molnar, BS, SCT (ASCP)CM, CT(IAC)
Department of Pathology, University of Toledo Medical Center
Toledo, OH
Nominee for region 5 director (Connecticut, Delaware, Washington DC, Eastern Canada, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island, Vermont, Virginia):
Eric Dufour, MS, CT(ASCP)
Rutland Regional Medical Center
Rutland, VT
Members residing in Regions 1, 3 and 5 will vote for BOTH the president-elect and the regional director for their respective region. Members residing in regions 2 and 4 will vote for ONLY the president-elect.
Voting closes on May 15th!
Click here to vote.
 |
|
The F-50 Non-Gyn Slide Processor has a liquid-based cytology system that features more cells per slide, and doesn’t need duplicate preps. The dual filtration disposable filters remove non-diagnostic material to optimize cell presentation. Cells of interest are transferred to the slide in a homogenous thin-layer cell deposit. Throughput: 50 samples/hr.
|
|
| Date |
Event |
Location |
More information |
June 2020 |
Soft Tissue and Bone FNA
|
Your PC |
Dr. Benjamin Witt
Associate Professor of Anatomic Pathology
University of Utah/ARUP Laboratories
Salt Lake City, Utah
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
CAP Today
Along with SARS-CoV-2, clinical laboratory testing has been hiding in plain sight far longer than many people realize. But it took the novel coronavirus (which, frankly, hardly feels novel anymore) to make that clear to the rest of the world. As the COVID-19 pandemic spread across the globe, laboratory testing crashed the news cycle. National leaders sought to reassure citizens by promising millions of test kits. Economies shattered — and have since sought to return to life — based on testing availability. Ordinary people woke before dawn to wait in lines at drive-through testing sites—often to be turned away when supplies ran out. Emergency use authorization became a common phrase. And behind every heartbreaking photo from an emergency department or ICU lingered an unnerving thought: We don’t have tests.
READ MORE
MedPage Today
According to study findings published in the Journal of Clinical Oncology, a blood test for tumor-associated HPV-DNA had near-perfect accuracy for identifying oropharyngeal squamous cell carcinoma patients at high risk of recurrence after treatment. The findings have clear and immediate implications for clinical practice, including earlier initiation of salvage therapy for patients with recurrent disease, reported Bhishamjit S. Chera, MD, of the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and colleagues.
READ MORE
|
|
|
|
|
| |
STAT
As it became clear in March that the coronavirus was tearing through the U.S., federal health officials and cancer societies urged Americans to delay their routine mammograms and colonoscopies. The public has heeded those recommendations — and that’s helped lead to an apocalyptic drop in cancer screenings, according to a white paper released recently by the electronic medical records vendor Epic.
READ MORE
CureToday
Obesity was associated with increased cardiovascular disease-related mortality and all-cause mortality, as well as potentially increased prostate cancer-specific mortality, in survivors of nonmetastatic prostate cancer, according to data published in the Journal of Clinical Oncology.
READ MORE
HealthCare Business
People with cancer who develop COVID-19 are much more likely to die from the disease than those without cancer, according to physician-researchers at Montefiore Health System and Albert Einstein College of Medicine. The study, published in the online edition of Cancer Discovery, is the largest so far to assess outcomes for patients with cancer who have also been infected with COVID-19.
READ MORE
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
